These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 2881524)
1. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics. Wallin JD; Shah SV Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524 [TBL] [Abstract][Full Text] [Related]
2. Beta-blockers in hypertension. Hansson L J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813 [TBL] [Abstract][Full Text] [Related]
3. Do we need a new classification of beta-blockers? Kendall MJ J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460 [TBL] [Abstract][Full Text] [Related]
5. Beta blockers in hypertension: a review. Kelly KL Am J Hosp Pharm; 1976 Dec; 33(12):1284-90. PubMed ID: 11687 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)]. Lemmer B Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492 [TBL] [Abstract][Full Text] [Related]
7. Managing the elderly patient with both hypertension and pulmonary disease. Krane NK; Wallin JD Geriatrics; 1987 Apr; 42(4):45-9, 52. PubMed ID: 2881848 [TBL] [Abstract][Full Text] [Related]
8. The role of the new beta-blockers in treating cardiovascular disease. Weber MA Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195 [TBL] [Abstract][Full Text] [Related]
9. [Clinical application of beta-blockers with particular reference to hypertension]. Kocijancić M Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():10-6. PubMed ID: 18193806 [TBL] [Abstract][Full Text] [Related]
10. Mode of action of beta-adrenergic blocking drugs in hypertension. Prichard BN; Owens CW Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756 [TBL] [Abstract][Full Text] [Related]
11. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension. Prichard BN; Saul PA J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141 [TBL] [Abstract][Full Text] [Related]
12. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension? Kountz DS Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810 [TBL] [Abstract][Full Text] [Related]
13. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment. Imhof P Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568 [TBL] [Abstract][Full Text] [Related]
14. Beta-blockers and hypertension: carbon copies or a real choice. Whipps RG; Fisher ML; Plotnick GD Compr Ther; 1984 Sep; 10(9):12-8. PubMed ID: 6149036 [TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension]. Widimský J Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840 [TBL] [Abstract][Full Text] [Related]
16. Differences in betablocking drugs in cardiovascular therapy. Iisalo E; Heikkilä J Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877 [TBL] [Abstract][Full Text] [Related]
17. The role of beta-blockers as a cornerstone of cardiovascular therapy. Hollenberg NK Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194 [TBL] [Abstract][Full Text] [Related]